
Venture capital · Early stage
InVivium Capital
InVivium Capital is a Chicago-based venture capital fund that invests in healthcare and life sciences, with a main focus on biotechnology and medical devices.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is InVivium Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds InVivium Capital joined, from press and the firm’s own posts.
Every round InVivium Capital joined
Round sizes, InVivium Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company InVivium Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet InVivium Capital
Events where InVivium Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
InVivium Capital is based in Chicago, United States.
1 fund vehicle is on public registers (SEC adviser filings), including INVIVIUM CAPITAL, LP.
Stages: Seed. Sectors: Life sciences, Biotech, Medtech. From the firm’s own website.
InVivium Capital lists 7 portfolio companies on its website, including Alto Neuroscience, Avalyn Pharma, Grove Biopharma, Hinge Bio and Onchilles Pharma.
Firms whose websites list some of the same companies include Agent Capital, Arboretum Ventures and Catalio Capital Management.
Know before InVivium Capital’s next round is announced.
PRO tracks InVivium Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.